These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1097095)

  • 1. Acute monocytic leukemia in children and its response to vinblastine (NSC-49842).
    Geiser CF; Mitus JW
    Cancer Chemother Rep; 1975; 59(2 Pt 1):385-8. PubMed ID: 1097095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).
    Albo V; Movassaghi N; Sitarz AL; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(6):1097-102. PubMed ID: 769949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of monocytic blast leukosis with vinblastine].
    Tomov K; Georgiev Z
    Vutr Boles; 1975; 14(6):56-8. PubMed ID: 1063500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission induction in childhood leukemia with second course vincristine (NSC-67574) and prednisone (NSC-10023) therapy.
    Cancer Chemother Rep; 1970 Apr; 54(2):113-8. PubMed ID: 4946001
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD
    Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of acute lymphoblastic leukemia].
    Paolucci G; Rosito P
    Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
    [No Abstract]   [Full Text] [Related]  

  • 7. [1973 treatment of acute leukemias].
    Danieli G
    Minerva Med; 1974 Dec; 65(90):4742-53. PubMed ID: 4141485
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute leukaemia of adults in Auckland: biological characteristics and survival.
    Buchanan JG; Bensley KE
    N Z Med J; 1969 Jul; 70(446):1-6. PubMed ID: 5258863
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute leukemia. Case material and therapeutic results].
    Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
    Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of acute leukemia in adults].
    Stavem P; Gjemdal T
    Tidsskr Nor Laegeforen; 1971 Nov; 91(33):2410-8. PubMed ID: 5289258
    [No Abstract]   [Full Text] [Related]  

  • 11. Histiocytosis X--comparison of three treatment regimens.
    Lahey ME
    J Pediatr; 1975 Aug; 87(2):179-83. PubMed ID: 1167297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia.
    Ellison RR; Hoogstraten B; Holland JF; Levy RN; Lee SL; Silver RT; Leone LA; Cooper T; Oberfield RA; Ten Pas A; Blom J; Jacquillat C; Haurani F
    Cancer Chemother Rep; 1972 Aug; 56(4):535-42. PubMed ID: 4507688
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy of acute leukaemia in adults. Comparison of two schedules.
    Scand J Haematol; 1974; 12(5):341-5. PubMed ID: 4527707
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M; Uetani T; Morita A; Sako F; Koie K
    Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute myelogenous leukemia in children: results of the cooperative BFM-78 therapy study after 3 3/4 years].
    Creutzig U; Ritter J; Langermann HJ; Riehm H; Henze G; Niethammer D; Jürgens H; Stollmann B; Lasson U; Kabisch H; Wahlen W; Löffler H; Schellong G
    Klin Padiatr; 1983; 195(3):152-60. PubMed ID: 6576202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Pure" monocytic or histiomonocytic leukemia: a revised concept.
    Shaw MT; Nordquist RE
    Cancer; 1975 Jan; 35(1):208-14. PubMed ID: 45889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug trials in neuroblastoma: cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone.
    Starling KA; Sutow WW; Donaldson MH; Land VJ; Lane DM
    Cancer Chemother Rep; 1974; 58(5 Pt 1):683-8. PubMed ID: 4426047
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 20. Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia.
    Van Echo DA; Lichtenfeld KM; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1599-602. PubMed ID: 72605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.